Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Lrig1 could be a marker for advanced sebaceous carcinoma.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Overexpression of LRIG3 in skin causes hair loss.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Analog 23 is a promising compound for prostate cancer treatment.

RANKL helps regenerate lung cells, potentially aiding lung repair in diseases like COPD.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.